The Looming Fiscal Crisis Over Revolutionary Weight Loss Drugs

• America faces a fiscal crisis over revolutionary weight loss drugs like Ozempic and Wegovy.
• These drugs, produced by Novo Nordisk, have potential cardiovascular, mental health, and anti-cancer benefits.
• However, their high cost in the U.S. compared to other countries could bankrupt Medicare.
• If half of U.S. adults with obesity took these drugs, it would cost $411 billion annually.
• The State Treasurer of North Carolina, Dale Folwell, is questioning the high cost and has asked the federal government to negotiate with Novo Nordisk to open up patents to generic manufacturers.

Source: More Perfect Union